Previously reported Phase 1/2 data on WU-CART-007 demonstrated clinically manageable safety and evidence of anti-leukemic activity with an overall response rate of 91% and composite complete remission ...

Ocugen has received approval from the DSMB to begin dosing the second cohort of patients in a trial of OCU200 for diabetic ...

The trial’s primary objective is to assess PALI-2108’s tolerability, pharmacokinetics and safety in healthy volunteers.

Whether with shots, gum or espressos, players are getting their caffeine fix more than ever to boost performance ...

A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of ...

Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide ...

An expert discusses how the availability of subcutaneous (SC) immune checkpoint inhibitors (ICI) for bladder cancer impacts ...

The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

The trial aims to assess the therapy’s tolerability, pharmacokinetics, pharmacodynamics and safety. Credit: Volha_R / Shutterstock. US-based biopharmaceutical company Palisade Bio has begun dosing ...

The Georgia Department of Early Care and Learning (DECAL) issued an order for the emergency closure of Forsyth Methodist ...

Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in people with obesity.

Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being treated with INST (Integrase Strand Transfer) inhibitor antiretrovirals, Gillian ...